Brainsway (Israel) Performance
| BRIN Stock | 1,803 47.00 2.54% |
On a scale of 0 to 100, Brainsway holds a performance score of 13. The firm shows a Beta (market volatility) of 0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Brainsway's returns are expected to increase less than the market. However, during the bear market, the loss of holding Brainsway is expected to be smaller as well. Please check Brainsway's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Brainsway's price patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Brainsway sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Brainsway |
Brainsway Relative Risk vs. Return Landscape
If you would invest 145,000 in Brainsway on September 12, 2024 and sell it today you would earn a total of 35,300 from holding Brainsway or generate 24.34% return on investment over 90 days. Brainsway is generating 0.522% of daily returns and assumes 3.127% volatility on return distribution over the 90 days horizon. Simply put, 27% of stocks are less volatile than Brainsway, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Brainsway Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brainsway's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brainsway, and traders can use it to determine the average amount a Brainsway's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1669
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BRIN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.13 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.52 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Brainsway is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brainsway by adding it to a well-diversified portfolio.
Brainsway Fundamentals Growth
Brainsway Stock prices reflect investors' perceptions of the future prospects and financial health of Brainsway, and Brainsway fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brainsway Stock performance.
| EBITDA | (3.89 M) | |||
| Cash And Equivalents | 9.07 M | |||
| Cash Per Share | 0.55 X | |||
| Total Debt | 2.83 M | |||
| Debt To Equity | 40.70 % | |||
| Book Value Per Share | 0.42 X | |||
| Cash Flow From Operations | (3.77 M) | |||
| Earnings Per Share | (0.39) X | |||
| Total Asset | 22 M | |||
| Retained Earnings | (47 M) | |||
| Current Asset | 15 M | |||
| Current Liabilities | 5 M | |||
About Brainsway Performance
By analyzing Brainsway's fundamental ratios, stakeholders can gain valuable insights into Brainsway's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brainsway has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brainsway has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel. Brainsway Ltd operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 96 people.Things to note about Brainsway performance evaluation
Checking the ongoing alerts about Brainsway for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brainsway help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brainsway appears to be risky and price may revert if volatility continues | |
| Brainsway has accumulated about 9.07 M in cash with (3.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55. |
- Analyzing Brainsway's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brainsway's stock is overvalued or undervalued compared to its peers.
- Examining Brainsway's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brainsway's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brainsway's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brainsway's stock. These opinions can provide insight into Brainsway's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |